| #36 |
Xudong Jiang |
Ninebot (Beijing) Tech Co. |
4 |
| #36 |
Nanjing Zhang |
Ptc Therapeutics |
4 |
| #53 |
Kyle T. Tarantino |
Johnson & Johnson |
3 |
| #53 |
Alexander T. Kozhich |
Bristol-Myers Squibb |
3 |
| #53 |
Israel Amir |
Centrak |
3 |
| #53 |
David Anthony Campana |
Thomson Licensing |
3 |
| #53 |
Linpeng Tang |
Meta |
3 |
| #53 |
Kevin Kwong-Tai Chung |
Amerasia International Technology |
3 |
| #53 |
Kumar Ramaswamy |
Thomson Licensing |
3 |
| #53 |
Xinyi Wei |
Basf Se |
3 |
| #53 |
Samuil R. Umansky |
Trovagene |
3 |
| #53 |
Guohua Zhao |
Bristol-Myers Squibb |
3 |
| #53 |
David Zenan Li |
Comcast |
3 |
| #53 |
John T. Groves |
Princeton University |
3 |
| #53 |
Michael S. Weaver |
Idemitsu Kosan Co. |
3 |
| #53 |
Rajesh Dave |
New Jersey Institute Of Technology |
3 |
| #53 |
Parikshit A. Deshpande |
Bionano Genomics |
3 |
| #53 |
Yi Yang |
Nec |
3 |
| #53 |
Bruce A. Ellsworth |
Bristol-Myers Squibb |
3 |
| #53 |
Kenneth G. Carson |
Millennium Pharmaceuticals |
3 |
| #53 |
Jani Reijonen |
Schlumberger Technology |
3 |
| #53 |
Francisco Pereira |
Caltech |
3 |
| #53 |
Bonnie L. Bassler |
Princeton University |
3 |
| #53 |
George Herbert Needham Riddle |
Sarnoff |
3 |
| #53 |
John S. Tokarski |
Bristol-Myers Squibb |
3 |
| #53 |
Livio Dalloro |
Siemens Aktiengesellschaft |
3 |
| #53 |
Yaowen Li |
Ofs Fitel |
3 |
| #53 |
Vadim Boguslavskiy |
Veeco Instruments |
3 |
| #53 |
Martin F. Semmelhack |
Princeton University |
3 |
| #53 |
Vijay H. Naringrekar |
Bristol-Myers Squibb |
3 |
| #81 |
Ming-Fang Huang |
Nec |
2 |
| #81 |
Guang Cao |
ExxonMobil |
2 |
| #81 |
Lawrence Adam Wolf |
Arable Labs |
2 |
| #81 |
Ryan M. Moslin |
Bristol-Myers Squibb |
2 |
| #81 |
Dinkar N. Bhat |
Arris Enterprises |
2 |
| #81 |
Timothy A. Blizzard |
Merck |
2 |
| #81 |
Jianming Bao |
Merck |
2 |
| #81 |
Bhadrinarayana Lalgudi Visweswaran |
Apple |
2 |
| #81 |
Evan Rogers |
Calcimedica |
2 |
| #81 |
Sridhar Seetharaman |
Bank of America |
2 |
| #81 |
Ruby B. Lee |
— |
2 |
| #81 |
Evgenii Yuryevich Kotelnikov |
Argo Ai |
2 |
| #81 |
Ian Redmond |
Dphi Acquisitions |
2 |
| #81 |
Qing Shi |
Eli Lilly |
2 |
| #81 |
Anjur Sundaresan Krishnakumar |
Avaya |
2 |
| #81 |
Atu Agawu |
Covidien Lp |
2 |
| #81 |
Jill Burstein |
— |
2 |
| #81 |
Stephen Sekelsky |
Lockheed Martin |
2 |
| #81 |
Ming Lei |
Novartis Ag |
2 |
| #81 |
Robert E. Tarjan |
Intertrust Technologies |
2 |